trending Market Intelligence /marketintelligence/en/news-insights/trending/4wFJKWTVaiTKcv0Rx3bvXg2 content esgSubNav
In This List

Exact Sciences plans underwritten public offering for common stock

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Exact Sciences plans underwritten public offering for common stock

Exact Sciences Corp. plans to sell 7 million common shares in an underwritten public offering.

The company has also granted underwriters an option to purchase up to 1,050,000 additional shares.

Exact Sciences plans to use the net proceeds to fund the expansion of Cologuard commercialization activities including to increase laboratory, manufacturing and customer service capacity, to fund product development efforts, and for general corporate and working capital purposes.

Jefferies LLC, BofA Merrill Lynch and Robert W. Baird & Co. Inc. are acting as underwriters for the offering.